TOI The Oncology Institute, Inc. - Common Stock
$4.06
Price · May 20, 2026
52W Range
$2–$5
71% of range
Analyst Rating
BUY
8 analysts
Price Target
$7
+72% upside
P/E (TTM)
—
ROE
—
Net Profit Margin
—
TOI Stock Snapshot Price, market cap, P/E, EPS, ROE, debt/equity, 52-week range
Price
$4.06
Market Cap
—
P/E (TTM)
—
EPS (TTM)
—
Revenue (TTM)
—
Div Yield
—
ROE
—
Debt/Equity
—
52W Range
$2 – $5
TOI Stock Price Chart Daily OHLCV with technical indicators — pan, zoom, and customize your view
Configure
10-Year Performance Revenue, net income, margins and EPS trends
Revenue & Net Income
—
EPS
—
Free Cash Flow
—
Margins
—
Valuation P/E, P/S, P/B, EV/EBITDA ratios — is the stock expensive or cheap?
Metric
5Y trend
TOI
Peer Median
Profitability Gross, operating and net margins; ROE, ROA, ROIC
Metric
5Y trend
TOI
Peer Median
Financial Health Debt, liquidity, solvency — balance sheet strength
Metric
5Y trend
TOI
Peer Median
Growth Revenue, EPS and net income growth: YoY, 3Y CAGR, 5Y CAGR
Metric
5Y trend
TOI
Peer Median
Capital Efficiency Asset turnover, inventory turnover, receivables turnover
Metric
5Y trend
TOI
Peer Median
TOI Analyst Consensus Bullish and bearish analyst opinions, 12-month price target, upside
BUY
8 analysts
- Strong Buy 2 25.0%
- Buy 5 62.5%
- Hold 1 12.5%
- Sell 0 0.0%
- Strong Sell 0 0.0%
12-Month Price Target
4 analysts · 2026-05-18
Median
$7.50
Mean
$7.00
← Below all targets
$4.06
Low
$5.00
High
$8.00
Median target
$7.50
+84.7%
Mean target
$7.00
+72.4%
Earnings History EPS actual vs estimate, surprise %, beat rate, next earnings date
Avg Surprise
0.01%
| Period | EPS Actual | EPS Est | Surprise |
|---|---|---|---|
| March 31, 2026 | $-0.02 | $-0.08 | 0.06% |
| Dec. 31, 2025 | $-0.06 | $-0.09 | 0.03% |
| Sept. 30, 2025 | $-0.14 | $-0.11 | -0.03% |
| June 30, 2025 | $-0.15 | $-0.13 | -0.02% |
| March 31, 2025 | $-0.17 | — | — |
Peer Comparison Key metrics vs sector peers
| Ticker | Market Cap | P/E | Rev YoY | Net Margin | ROE | Gross Margin |
|---|---|---|---|---|---|---|
| TOI | — | — | — | — | — | — |
| SGRY | $2.00B | -25.3 | 6.2% | -2.4% | -4.5% | — |
| SNDA | $612M | -7.7 | 25.2% | -18.6% | -197.2% | — |
| ARDT | $1.26B | 9.2 | 6.0% | 2.1% | 11.2% | — |
| USPH | — | 55.0 | 16.3% | 5.1% | 8.2% | 19.2% |
| NUTX | $1.17B | 15.7 | 82.4% | 8.1% | 30.6% | 50.8% |
| CYH | $433M | 0.8 | -1.2% | 4.1% | -30.8% | — |
| JYNT | $123M | 45.9 | 5.2% | 5.3% | 16.3% | — |
| HCA | $104.86B | 16.5 | 7.1% | 9.0% | -159.1% | — |
Latest News Recent headlines mentioning this company
My Metrics Your personal watchlist — selected rows from Full Fundamentals
📊
Pick the metrics that matter to you — click the ➕ next to any row in Full Fundamentals above.
Your selection is saved and follows you across all tickers.